About COMPASS Pathways plc
https://compasspathways.comCOMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder.
CEO
Kabir Kumar Nath
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 14
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
BTIG
Buy
HC Wainwright & Co.
Buy
Canaccord Genuity
Buy
RBC Capital
Outperform
Morgan Stanley
Overweight
Cantor Fitzgerald
Overweight
Grade Summary
Showing Top 6 of 7
Price Target
Institutional Ownership
RTW INVESTMENTS, LP
Shares:8.71M
Value:$66.44M
DEEP TRACK CAPITAL, LP
Shares:7.86M
Value:$59.97M
GMT CAPITAL CORP
Shares:2.84M
Value:$21.7M
Summary
Showing Top 3 of 177
About COMPASS Pathways plc
https://compasspathways.comCOMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $40.54M ▼ | $-137.72M ▼ | 0% | $-1.44 ▼ | $-136.83M ▼ |
| Q2-2025 | $0 | $42.93M ▼ | $-38.4M ▼ | 0% | $-0.41 ▼ | $-36.96M ▼ |
| Q1-2025 | $0 | $49.62M ▲ | $-17.86M ▲ | 0% | $-0.2 ▲ | $-16.35M ▲ |
| Q4-2024 | $0 | $48.41M ▲ | $-43.33M ▼ | 0% | $-0.63 ▼ | $-41.13M ▼ |
| Q3-2024 | $0 | $47.9M | $-38.5M | 0% | $-0.56 | $-37.13M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $185.94M ▼ | $255.61M ▼ | $218.02M ▲ | $37.59M ▼ |
| Q2-2025 | $221.88M ▼ | $293.54M ▼ | $130.98M ▲ | $162.56M ▼ |
| Q1-2025 | $260.11M ▲ | $319.13M ▲ | $123.67M ▲ | $195.47M ▲ |
| Q4-2024 | $165.08M ▼ | $213.67M ▼ | $58.97M ▲ | $154.69M ▼ |
| Q3-2024 | $206.95M | $247.34M | $54.31M | $193.03M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-137.72M ▼ | $-35.11M ▲ | $0 | $0 ▼ | $-35.94M ▲ | $-35.11M ▲ |
| Q2-2025 | $-38.4M ▼ | $-38.69M ▲ | $0 | $166K ▼ | $-38.23M ▼ | $-38.69M ▲ |
| Q1-2025 | $-17.86M ▲ | $-45.66M ▼ | $0 | $140.36M ▲ | $95.02M ▲ | $-45.66M ▼ |
| Q4-2024 | $-43.33M ▼ | $-41.76M ▼ | $0 | $155K ▲ | $-41.87M ▼ | $-41.76M ▼ |
| Q3-2024 | $-38.5M | $-22.18M | $0 | $-53K | $-21.68M | $-22.18M |
CEO
Kabir Kumar Nath
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 14
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
BTIG
Buy
HC Wainwright & Co.
Buy
Canaccord Genuity
Buy
RBC Capital
Outperform
Morgan Stanley
Overweight
Cantor Fitzgerald
Overweight
Grade Summary
Showing Top 6 of 7
Price Target
Institutional Ownership
RTW INVESTMENTS, LP
Shares:8.71M
Value:$66.44M
DEEP TRACK CAPITAL, LP
Shares:7.86M
Value:$59.97M
GMT CAPITAL CORP
Shares:2.84M
Value:$21.7M
Summary
Showing Top 3 of 177